Skip to main content
. 2020 Jun 5;10(16):7335–7350. doi: 10.7150/thno.45971

Figure 6.

Figure 6

Expression patterns of miR-139-5p and its targets in human CRC tissues. (A) ISH of miR-139-5p and IHC of JUN, FOS, CTNNB1, DVL1 and ZEB1 expression in WT (KRASWT) and KRAS-mutant (KRASMT) CRC tissues from the XHDD cohort. Bars: 100 µm (main); 500 µm (inset). (B) Associations between miR-139-5p expression and JUN, FOS, CTNNB1, DVL1 and ZEB1 expression in the XHDD cohort CRC tissues. *P<0.05; **P<0.01. (C) Correlations between the mRNA expression levels of miR-139-5p and those of JUN, FOS, CTNNB1, DVL1 and ZEB1 in XHDD cohort CRC tissues.